Article Information
History
- July 17, 2020.
Article Versions
- You are currently viewing Version 1 of this article (July 17, 2020 - 23:56).
- Version 2 (August 25, 2020 - 18:54).
- Version 3 (October 19, 2020 - 10:54).
- Version 4 (December 24, 2020 - 14:36).
- View Version 5, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Xaquín Castro Dopico1,#,
- Leo Hanke1,°,
- Daniel J. Sheward1,°,
- Murray Christian1,
- Sandra Muschiol2,
- Nastasiya F. Grinberg3,
- Monika Adori1,
- Laura Perez Vidakovics1,
- Kim Chang II1,
- Sharesta Khoenkhoen1,
- Pradeepa Pushparaj1,
- Ainhoa Moliner Morro1,
- Marco Mandolesi1,
- Mattias Forsell4,
- Jonathan Coquet1,
- Martin Corcoran1,
- Joanna Rorbach5,6,
- Soo Aleman7,
- Gordana Bogdanovic2,
- Gerald McInerney1,
- Tobias Allander1,2,
- Chris Wallace3,8,
- Ben Murrell1,*,
- Jan Albert1,2,* and
- Gunilla B. Karlsson Hedestam1,#
- 1Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm 171 77, Sweden
- 2Department of Clinical Microbiology, Karolinska University Hospital, Stockholm 171 76, Sweden
- 3Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, University of Cambridge, Cambridge, CB2 0AW
- 4Department of Clinical Microbiology, Umeå Universitet, Umeå 901 85, Sweden
- 5Department of Molecular Biochemistry & Biophysics, Karolinska Institutet, Stockholm 171 77, Sweden
- 6Max Planck Institute-Biology of Ageing, Karolinska Institutet Laboratory, Stockholm 171 77, Sweden
- 7Department of Infectious Diseases, Karolinska Universitetssjukhuset, Huddinge 141 52, Sweden
- 8MRC Biostatistics Unit, Cambridge Institute of Public Health, Cambridge CB2 0SR, United Kingdom
- ↵#Correspondence; Email: xaquin.castro.dopico{at}ki.se
↵°* Equal contribution
Posted July 17, 2020.
Disease-associated antibody phenotypes and probabilistic seroprevalence estimates during the emergence of SARS-CoV-2
